From foundations to fulfillment
For cancer care in North Texas, 2005–2015 was a defining decade. Ten years ago the Simmons Comprehensive Cancer Center set the loftiest of goals—to meet the community’s many and varied cancer-related needs through:
- Outstanding achievement in biomedical research
- Exceptional patient care
- A rich training environment for the physicians and scientists of tomorrow
- Aggressive outreach to provide more North Texans with life-saving prevention and early detection
In just five years, the Simmons Cancer Center earned National Cancer Institute (NCI) designation recognizing achievement in those areas, a milestone that also has opened some of the most advanced national clinical trials to local cancer patients. And now, after just another five years, Simmons has been awarded “comprehensive” designation from the NCI, becoming one of only three such top-tier institutions in the state, and the only one in North Texas. The designation recognizes superior cancer care and prevention programs, along with pace-setting science and technology.
Those strides testify to the commitment of the Cancer Center’s more than 170 members—the people behind the ideas, inspiration, industry, and innovation that have propelled a decade of progress in the lab, the clinic, and the community. But this decade of achievement also was not possible without a vanguard of visionaries who had set in place the cornerstones upon which today’s Cancer Center has been built. Learn about the foundation for the Simmons Cancer Center.
Timeline of achievement
In 1988, a $41 million gift from Dallas businessman Harold Simmons and his wife, Annette, provided seminal funds to transform cancer research and care at UT Southwestern. In 1991, the Harold C. Simmons Comprehensive Cancer Center was established. Learn about the Simmons Comprehensive Cancer Center's many achievements.
The decade ahead
Important advances over the next decade will help Simmons Cancer Center realize the power and the promise of precision medicine for North Texas cancer patients. These key areas of progress include:
- Delivery of radiation therapy
- Clinical trials leadership
- Cross-disciplinary collaboration
- Drug development
- Innovative discovery
- A UT Southwestern genomic panel